EBS 14.55 -0.07 / Emergent Biosolutions EBS 14.55 -0.07 / Emergent Biosolutions M&A | Benzinga

Monday, January 09, 2012

Financial Breakfast: Morning News Summary for January 9, 2012 (ANF, BMY, Earnings, EBS, INHX, INSP, MR, News, NFLX, SPRD, TRV, Futures, Guidance, Upgrades, Commodities, Downgrades, Forex, Technicals, FDA, M&A, Events, Global, Econ #s, Economics, Pre-Market Outlook, Markets, Analyst Ratings, Tech, Trading Ideas, General / Mon, 08:26am)

Monday, June 06, 2011

Emergent BioSolutions Acquires Late-Stage Monoclonal Antibody Cancer Therapy from TenX BioPharma (EBS, News, M&A / Mon, 07:04am)

Thursday, December 30, 2010

First California to Acquire Division of Palm Desert National Bank (EBS, FCAL, News, M&A / Thu, 04:30pm)

Wednesday, September 08, 2010

Trubion Pharmaceuticals Announces Early Termination of HSR Waiting Period (EBS, TRBN, Politics, M&A / Wed, 04:05pm)
Emergent BioSolutions Announces Early Termination of HSR Waiting Period for Its Acquisition of Trubion Pharmaceuticals (EBS, M&A / Wed, 04:02pm)

Friday, August 13, 2010

Benzinga’s Top Pre-Market NASDAQ Gainers (UNCA, PRXI, TRBN, VECO) (EBS, IBM, Long Ideas, News, PRXI, TRBN, UNCA, VECO, M&A, Pre-Market Outlook, Intraday Update, Markets, Movers, Trading Ideas / Fri, 09:19am)